{
  "success": true,
  "pagesUsed": [
    2,
    4,
    10,
    12,
    15,
    17,
    20,
    25,
    27,
    29,
    32,
    37,
    39,
    40,
    41,
    42,
    57
  ],
  "modelUsed": "gemini-2.5-pro",
  "confidence": 1.0,
  "scheduling": {
    "timings": [
      {
        "id": "timing_1",
        "name": "End of Study Visit Window",
        "type": {
          "id": "cb76d585-8b0a-4f6c-822f-29c74418fbeb",
          "code": "C71148",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Fixed Reference",
          "instanceType": "Code"
        },
        "value": "P54D",
        "valueLabel": "Day 54",
        "relativeToFrom": {
          "id": "7bb8868f-94d8-4895-ae03-d3b223ca91a8",
          "code": "C71155",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "First Dose",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "8885dbd6-1887-4973-be76-ad6d3787ec20",
        "instanceType": "Timing",
        "windowLower": "-P2D",
        "windowUpper": "P2D"
      },
      {
        "id": "timing_2",
        "name": "Zinc Therapy Washout",
        "type": {
          "id": "b6ea751b-d32c-40a5-a751-6c09da6ad967",
          "code": "C71149",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Before",
          "instanceType": "Code"
        },
        "value": "P21D",
        "valueLabel": "Day 21",
        "relativeToFrom": {
          "id": "51aac0c8-5f44-4482-8d5c-33c8ee0131de",
          "code": "C71155",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "First Dose",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "17b3d912-37e9-4b8b-91c9-e26c95a2f083",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_3",
        "name": "Experimental Therapy Washout",
        "type": {
          "id": "b1330cbe-ef42-4210-ad6c-b8d1e8ce4406",
          "code": "C71149",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Before",
          "instanceType": "Code"
        },
        "value": "P90D",
        "valueLabel": "Day 90",
        "relativeToFrom": {
          "id": "5c73ea95-b469-4ba6-ba3f-7edbe9f213ab",
          "code": "C71158",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Screening",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "e8af1b9f-3dea-4906-b265-6b1061714526",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_4",
        "name": "Prescription Medication Washout",
        "type": {
          "id": "211a1cbc-321f-4f51-ab01-6b7388d19a98",
          "code": "C71149",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Before",
          "instanceType": "Code"
        },
        "value": "P14D",
        "valueLabel": "Day 14",
        "relativeToFrom": {
          "id": "f931a769-346d-4ffc-ab26-3ab1daa01fa3",
          "code": "C71153",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Study Start",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "6dc46e83-67f1-4c21-8505-003bd9706f9d",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_5",
        "name": "Non-Prescription Medication Washout",
        "type": {
          "id": "b53906a9-99e3-49d7-b87e-0b96abd9fd98",
          "code": "C71149",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Before",
          "instanceType": "Code"
        },
        "value": "P7D",
        "valueLabel": "Day 7",
        "relativeToFrom": {
          "id": "832baa3e-de9b-4f0e-a68c-6834671298cd",
          "code": "C71153",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Study Start",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "e4725310-ac9d-439f-867a-7060707c25fe",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_6",
        "name": "Alcohol Abstinence Prior to Dosing",
        "type": {
          "id": "32e36ca3-6588-46bd-b979-12608791a539",
          "code": "C71149",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Before",
          "instanceType": "Code"
        },
        "value": "PT48H",
        "valueLabel": "48 hours",
        "relativeToFrom": {
          "id": "3799ea69-633e-40f7-aed4-a331dc6db184",
          "code": "C71155",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "First Dose",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "60f4ed42-46d9-42e7-a3dc-66360ee2dd88",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_7",
        "name": "Outpatient Dosing Time Window",
        "type": {
          "id": "07b930e7-26f2-4416-9800-1608dcecd470",
          "code": "C71148",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Fixed Reference",
          "instanceType": "Code"
        },
        "value": "PT0H",
        "valueLabel": "0 hours",
        "relativeToFrom": {
          "id": "4be9afb8-7d6a-407c-b25f-902fc0236854",
          "code": "C71153",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Study Start",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "dd3b8d6d-7a31-4eaf-8f87-104782d575dd",
        "instanceType": "Timing",
        "windowLower": "-PT1H",
        "windowUpper": "PT1H"
      },
      {
        "id": "timing_8",
        "name": "Urine Pregnancy Test Frequency",
        "type": {
          "id": "bac4cfe3-9186-4e11-a4bb-fb442e5dbba8",
          "code": "C71150",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "After",
          "instanceType": "Code"
        },
        "value": "P4W",
        "valueLabel": "4 weeks",
        "relativeToFrom": {
          "id": "8c32f76a-c81f-4632-81a5-d46d1091c722",
          "code": "C71157",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Previous Visit",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "dd8c2d35-2560-4591-be01-07b52765c1eb",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_9",
        "name": "Dose Titration Timing",
        "type": {
          "id": "35840e3c-bdc1-4b26-8ba1-bc90939b776a",
          "code": "C71148",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Fixed Reference",
          "instanceType": "Code"
        },
        "value": "P29D",
        "valueLabel": "Day 29",
        "relativeToFrom": {
          "id": "cd39207f-b460-4c0e-831b-8b377db603f2",
          "code": "C71155",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "First Dose",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "c32161ec-5527-4469-81ab-1938586f9933",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_10",
        "name": "Chelator Therapy Washout",
        "type": {
          "id": "adfc19ba-e263-4dc4-bd14-d666d4bfc74b",
          "code": "C71149",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Before",
          "instanceType": "Code"
        },
        "value": "P4D",
        "valueLabel": "Day 4",
        "relativeToFrom": {
          "id": "d405af1c-acb7-4954-b240-018250828ab6",
          "code": "C71155",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "First Dose",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "f43a20e9-03a1-45fa-a245-ba112ffdc118",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_11",
        "name": "Tetrathiomolybdate Washout",
        "type": {
          "id": "e929f95b-fd55-46bd-a5bd-0dd5f657129e",
          "code": "C71149",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Before",
          "instanceType": "Code"
        },
        "value": "P1D",
        "valueLabel": "1 years",
        "relativeToFrom": {
          "id": "e54c44d3-8fd3-47d4-b8c1-663cd554d5bd",
          "code": "C71155",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "First Dose",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "1dd45979-25b8-4615-939d-8d011c4860f5",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_12",
        "name": "Catheter Dwell Time Limit",
        "type": {
          "id": "5361e194-247d-4a1f-a4e2-1086d34f9d99",
          "code": "C71151",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Within",
          "instanceType": "Code"
        },
        "value": "PT72H",
        "valueLabel": "72 hours",
        "relativeToFrom": {
          "id": "046740b0-500b-4bb2-852e-190d37287915",
          "code": "C71153",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Study Start",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "b325e159-d6ae-4a39-a9a2-e181992d4559",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      }
    ],
    "conditions": [
      {
        "id": "cond_1",
        "name": "Prerequisite for Dose Titration",
        "instanceType": "Condition",
        "description": "Safety Review Committee (SRC) must review safety data before dose titration to 30 mg/day.",
        "text": "Before titration to 30 mg/day, the Safety Review Committee (SRC) will review available safety data through Day 23 for each participant."
      },
      {
        "id": "cond_2",
        "name": "Outpatient Period Extension",
        "instanceType": "Condition",
        "description": "The outpatient period can be extended with Investigator approval.",
        "text": "To ensure flexibility, the Outpatient Period during Treatment Period 1 may be extended up to an additional 14 days with Investigator approval."
      },
      {
        "id": "cond_3",
        "name": "Dose Rechallenge Limit",
        "instanceType": "Condition",
        "description": "A maximum number of dose rechallenges is permitted following a dose modification.",
        "text": "A maximum of 3 rechallenges will be allowed."
      },
      {
        "id": "cond_4",
        "name": "Dosing Fasting and Meal Condition",
        "instanceType": "Condition",
        "description": "Conditions related to fasting and meal timing around study drug administration.",
        "text": "Study intervention will be administered after an overnight fast (ie, at least 10 hours)... meals should be delayed a minimum of 2 hours after dosing."
      },
      {
        "id": "cond_5",
        "name": "ALT/AST Elevation - Level 1",
        "instanceType": "Condition",
        "description": "Criteria for dose reduction due to moderate transaminase elevation.",
        "text": "ALT and/or AST > 3 to ≤ 5 × ULN"
      },
      {
        "id": "cond_6",
        "name": "ALT/AST Elevation - Level 2",
        "instanceType": "Condition",
        "description": "Criteria for dose interruption due to significant transaminase elevation.",
        "text": "ALT and/or AST > 5 to ≤ 8 × ULN"
      },
      {
        "id": "cond_7",
        "name": "ALT/AST Elevation - Level 3",
        "instanceType": "Condition",
        "description": "Criteria for study intervention discontinuation due to severe transaminase elevation.",
        "text": "ALT and/or AST > 8 × ULN"
      },
      {
        "id": "cond_8",
        "name": "Hemoglobin Decrease - Level 1",
        "instanceType": "Condition",
        "description": "Criteria for dose reduction due to moderate hemoglobin decrease.",
        "text": "Hemoglobin > 2 g/dL ↓ from baseline"
      },
      {
        "id": "cond_9",
        "name": "Hemoglobin Decrease - Level 2",
        "instanceType": "Condition",
        "description": "Criteria for dose interruption due to significant hemoglobin decrease.",
        "text": "Hemoglobin > 3 g/dL ↓ from baseline"
      },
      {
        "id": "cond_10",
        "name": "Platelet Decrease",
        "instanceType": "Condition",
        "description": "Criteria for dose reduction due to platelet decrease.",
        "text": "Platelets > 30% ↓ from baseline"
      },
      {
        "id": "cond_11",
        "name": "Neutrophil Decrease",
        "instanceType": "Condition",
        "description": "Criteria for dose reduction due to neutrophil decrease.",
        "text": "Neutrophils > 30% ↓ from baseline"
      },
      {
        "id": "cond_12",
        "name": "Hy's Law Condition",
        "instanceType": "Condition",
        "description": "Criteria for dose interruption due to concurrent bilirubin and ALT elevation.",
        "text": "Bilirubin > 2 × ULN Accompanied by ALT > 3 × ULN"
      },
      {
        "id": "cond_13",
        "name": "Neurologic Worsening",
        "instanceType": "Condition",
        "description": "Criteria for evaluating dose modification due to neurologic worsening.",
        "text": "Evidence of neurologic worsening by AEs or by neurologic physical exam assessment"
      }
    ],
    "conditionAssignments": [],
    "transitionRules": [
      {
        "id": "trans_1",
        "name": "Dose Titration to 30mg",
        "instanceType": "TransitionRule",
        "transitionType": "Dose Modification",
        "text": "Participants will be administered ALXN1840 at 15 mg/day for a treatment period of approximately 28 days followed by titration up to 30 mg/day on Day 29."
      },
      {
        "id": "trans_2",
        "name": "Dose Reduction for ALT/AST",
        "instanceType": "TransitionRule",
        "transitionType": "Dose Modification",
        "text": "If ALT and/or AST > 3 to ≤ 5 × ULN, reduce dose to previous dose level or 15 mg QOD if on 15 mg QD."
      },
      {
        "id": "trans_3",
        "name": "Dose Interruption for ALT/AST",
        "instanceType": "TransitionRule",
        "transitionType": "Dose Modification",
        "text": "If ALT and/or AST > 5 to ≤ 8 × ULN, temporarily interrupt dosing."
      },
      {
        "id": "trans_4",
        "name": "Discontinuation for ALT/AST",
        "instanceType": "TransitionRule",
        "transitionType": "Discontinuation",
        "text": "If ALT and/or AST > 8 × ULN, discontinue study intervention."
      },
      {
        "id": "trans_5",
        "name": "Dose Reduction for Hemoglobin",
        "instanceType": "TransitionRule",
        "transitionType": "Dose Modification",
        "text": "If Hemoglobin > 2 g/dL ↓ from baseline, reduce dose to previous dose level or 15 mg QOD if on 15 mg QD."
      },
      {
        "id": "trans_6",
        "name": "Dose Interruption for Hemoglobin",
        "instanceType": "TransitionRule",
        "transitionType": "Dose Modification",
        "text": "If Hemoglobin > 3 g/dL ↓ from baseline, temporarily interrupt dosing."
      },
      {
        "id": "trans_7",
        "name": "Discontinuation for Hypersensitivity",
        "instanceType": "TransitionRule",
        "transitionType": "Discontinuation",
        "text": "Participants must be considered for discontinuation from study intervention if a serious hypersensitivity reaction occurs."
      },
      {
        "id": "trans_8",
        "name": "Discontinuation for Infection",
        "instanceType": "TransitionRule",
        "transitionType": "Discontinuation",
        "text": "Participants must be considered for discontinuation from study intervention for a severe uncontrolled infection."
      },
      {
        "id": "trans_9",
        "name": "Discontinuation for Disallowed Medication",
        "instanceType": "TransitionRule",
        "transitionType": "Discontinuation",
        "text": "Participants must be considered for discontinuation from study intervention for use of disallowed medication."
      },
      {
        "id": "trans_10",
        "name": "Discontinuation for Pregnancy",
        "instanceType": "TransitionRule",
        "transitionType": "Discontinuation",
        "text": "Participants must be considered for discontinuation from study intervention for pregnancy or planned pregnancy."
      }
    ],
    "scheduleTimelineExits": [
      {
        "id": "exit_1",
        "name": "Study Completion",
        "exitType": "Completion",
        "instanceType": "ScheduleTimelineExit",
        "description": "A participant is considered to have completed the study if he/she has completed all phases of the study including the last scheduled procedure shown in the Schedule of Activities."
      },
      {
        "id": "exit_2",
        "name": "Voluntary Withdrawal",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "A participant may withdraw from the study at any time at his/her own request."
      },
      {
        "id": "exit_3",
        "name": "Investigator Discretionary Withdrawal",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "A participant may be withdrawn at any time at the discretion of the Investigator for safety, behavioral, compliance, or administrative reasons."
      },
      {
        "id": "exit_4",
        "name": "Lost to Follow-up",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "A participant will be considered lost to follow-up if he or she repeatedly fails to return for scheduled visits and is unable to be contacted by the study site after specified efforts."
      },
      {
        "id": "exit_5",
        "name": "Sponsor Study Termination",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "Alexion reserves the right to terminate the study at any time for any reason at the sole discretion of Alexion."
      }
    ],
    "scheduledDecisionInstances": [
      {
        "id": "dec_1",
        "name": "Dose Titration Decision",
        "timepointId": "pt_day29",
        "instanceType": "ScheduledDecisionInstance",
        "description": "Decision point on Day 29 to titrate dose from 15 mg/day to 30 mg/day, contingent on SRC safety review of data through Day 23.",
        "conditionIds": [
          "cond_1"
        ]
      },
      {
        "id": "dec_2",
        "name": "Ongoing Dose Modification Decision",
        "timepointId": "pt_ongoing",
        "instanceType": "ScheduledDecisionInstance",
        "description": "Ongoing decisions to modify, interrupt, or discontinue study intervention based on safety monitoring parameters for liver function, hematology, and clinical assessment.",
        "conditionIds": [
          "cond_5",
          "cond_6",
          "cond_7",
          "cond_8",
          "cond_9",
          "cond_10",
          "cond_11",
          "cond_12",
          "cond_13"
        ]
      }
    ],
    "summary": {
      "timingCount": 12,
      "conditionCount": 13,
      "transitionRuleCount": 10,
      "exitCount": 5
    }
  }
}